IVF OutcomesNCT04394962
Virtual Reality Use in Assisted Reproductive Technology
A study testing Virtual reality in people with IVF Outcomes and Stress Levels, run by Dr cliff Librach at 1 site in Canada.
Trial summary
The study will examine the effect of exposure to virtual reality on stress levels and pregnancy rates, in infertile women undergoing in vitro fertilization embryo transfer Read more about this study
- Who is it for?
- Ages 21 to 54 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- IVF Outcomes, Stress Levels
- What is being tested?
- Virtual reality
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 350 participants
- Where
- 1 siteCanada
- Study dates
- 31 May 2019to 1 Aug 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 21 to 54 years
- Women only
- Healthy volunteers accepted
- Adult
Who may be able to join
- 21-45-year-old female patients, if using own ovum. Patients above this age range may be approached for study if using a donated ovum, as long as "egg age" (age of donor at ovum pick up) falls in 21-45 age range.
- Undergoing frozen ET procedures, and approached for study on "Day 2 - Day 4" of ET transfer cycle.
- Ability to provide written consent to use VR technology before the ET procedure
Who cannot join
- Contraindication to use VR technology (Epilepsy/previous seizure, claustrophobia, current migraine, heart disease, visual and/or auditory deficits/use of medical devices such as cardiac pacemaker or hearing aids)
- Anxiety disorder and/or Regular use of anti-anxiety medications
- Major uterine anomalies and/or uterine fibroids distorting the cavity
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Use of Virtual Reality Technology in Infertile Women Undergoing in Vitro Fertilization-embryo Transfer: A Randomized Controlled Trial
The study will examine the effect of exposure to virtual reality on stress levels and pregnancy rates, in infertile women undergoing in vitro fertilization embryo transfer
Read the detailed description
In vitro fertilization (IVF) treatment involving ovarian stimulation, oocyte retrieval and embryo transfer (ET) is an effective treatment for various causes of infertility. Despite advances in ovarian stimulation regimens and laboratory conditions, many IVF cycles do not result in pregnancy, and repeated treatment cycles are required. According to the latest Assisted reproductive technology (ART) surveillance report in the United states, of 143,286 procedures that progressed to the ET stage, 50.9% resulted in a pregnancy and 41.4% in a live-birth. Achieving higher pregnancy and live birth rates remains a leading priority of IVF units worldwide. Both IVF practitioners and patients keep searching for new ways to improve reproductive outcomes.
IVF is a multidimensional stressor. The treatment itself constitutes the primary stressor and is most likely to evoke anxiety. The highest anxiety scores were experienced before embryo transfer and were comparable to anxiety scores obtained from surgical female patients in the immediate preoperative period. Hence, it is not surprising that ET is defined by many investigators as a crucial event for determining IVF outcome, and many patients perceive it as the culmination of the IVF treatment. The stress this procedure may cause can result in a variety of autonomous nervous system expressions, altered uterine gene expression, resulting in decreased uterine receptivity, or an increase in uterine contraction frequency, which may be inversely correlated to embryo implantation and pregnancy rates in IVF. Several studies found that women who did not become pregnant with IVF, reported experiencing more stress during treatment than those who achieved pregnancy.
Although the exact mechanism whereby stress interferes with reproductive processes is not fully understood, experimental evidence increasingly indicates that lower stress levels result in better fertility treatment outcome.
The use of complementary medicine or adjuvant therapies to reduce psychological stress during ART therapy and improve IVF outcomes is increasing. Various alternative therapies have been proposed to improve reproductive outcomes during IVF treatment, such as acupuncture and Chinese herbal medicines. However, the impact of these therapies on IVF outcomes was inconclusive.
The impact of medical clowning as a stress-reducing technique for 12-15 minutes after ET was found to increase the pregnancy rate - 36.4% in the intervention group compared with 20.2% in the control group. Other interventions, specifically prior or during the IVF-ET procedure itself have been studied in the context of improving cycle outcome and/or reducing anxiety levels.
In order to assess anxiety levels before and after interventions, most of these studies included the validated "State-Trait Anxiety Inventory" (STAI) questionnaire, which is a self-assessment questionnaire, consisting of 40 items rated on 4-point Likert scale. The scale consists of two sub-dimensions: the "state anxiety" has 20 items and is used to determine what is felt at a specific moment under certain conditions, and the "trait anxiety" has 20 items and is used to determine what has been felt in the last seven days. Higher scores are positively correlated with higher levels of anxiety. Other studies assessing stress related to ET procedure used salivary a-amylase (SAA). SAA measurement presents a non-invasive and a highly reliable indicator of sympathetic-adrenal medullary activity can be used as a physiologic indicator of the acute stress response.
The impact of hypnosis during ET on the outcome of IVF was studied in 89 patients, compared with controls. The results suggested that the use of hypnosis during ET may significantly improve the IVF-ET cycle outcome in terms of increased implantation rates (IR) and clinical pregnancy rates (CPR).
Harp therapy during ET of 90 IVF patients was found to significantly decrease levels of anxiety post transfer and having a positive effect on acute levels of stress, compared with controls. However, CPR was comparable between the harp group and the control group. Another study assessed the effectiveness of a deep relaxation massage therapy prior to frozen ET in 56 IVF patients. In patients using the massage therapy prior to ET, statistically significant increases in pregnancy and live birth rates were observed when compared with the control group (58.9% vs 41.7%, and 32.0% vs 20.3%, respectively). The researchers hypothesized these improvements were most likely due to a relaxing effect on patients and reduction in stress, leading to a reduction in uterine contractions.
A recent randomized controlled trial assessed the effect of music therapy in women undergoing IVF-ET. They examined the effect of music therapy before and after ET, on the anxiety levels and pregnancy rates in 89 IVF patients. The mean state anxiety scores decreased in both groups, however these changes did not reach statistical significance. CPR were comparable between the groups.
Virtual reality (VR) is a therapeutic approach which has been gaining attention over the past two decades for both medical and psychiatric purposes. VR is an advanced technological system that allows users to be transported into a 'virtual world'. Users are engaged in a fully immersive VR experience through a combination of technologies, including a head-mounted display, headphones with sound/music and noise reduction, and another device for manipulation/navigation of the virtual environment. Multimodal stimuli contribute to a sense of actual presence/immersion in the virtual world, thus making the VR experience distinct from a passive visual or auditory stimuli. Being a safe, non-invasive and easy to use technique, VR therapy has been explored for numerous health applications, showing positive outcomes in clinical conditions such as anxiety disorders, addictions, phobias, posttraumatic stress disorder, eating disorders, stroke rehabilitation, and pain management. A recent systematic review including 11 VR studies and 467 patients, concluded that VR's immersive, entertaining effects are useful for redirecting the patient's attention away from painful treatment experiences and reducing anxiety, discomfort, or unpleasantness. Other studies also showed a significant decrease in pain perception and state anxiety scores when treated with VR, as indicated by anxiety questionnaires, pulse rate reduction, and electroencephalogram (EEG) changes when treated with VR as compared with controls, all supporting the therapeutic potential of VR for anxiety management and stress reduction.
A study presented at the 2018 anesthesia congress in Europe (Unpublished data) compared the effect of two different VR sessions (distraction and hypnosis) before sedation, on the anxiety level and the following cycle outcomes in 100 IVF patients. The preliminary results of the study showed a reduction in the anxiety scores in both groups, however the differences between the groups did not reach statistical significance.
The aim of this study is to examine the effects of VR technology on the most stressful event during IVF-the transfer of embryos into the uterus. The investigators will use the STAI questionnaire to assess levels of anxiety experienced during the ET procedure, in participants exposed to VR session before the ET, compared with participants who are not exposed.
The investigators hypothesize that the use of this unique technology before the procedure may reduce stress levels and consequently improve implantation and pregnancy rates.
According to a recent literature review, there are no published studies examining the effect of VR prior to ET on IVF outcomes.
- Conditions
- IVF Outcomes, Stress Levels
- Being tested
- Virtual reality
- Keywords
- Virtual reality, In vitro fertilization, Embryo transfer
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Virtual realityDevice
Also called "Oculus Rift" system, Immersive environment
Patients randomized to the study group, will be provided with the VR headset and sensors. The VR exposure will take place before the ET procedure, during their routine pre-transfer waiting period, in a private room. The patient will be able to choose between three different calming VR environments (3 scenes: beach sunset, palm tree patio or redwood forest) and will be exposed to the chosen VR environment for a continuous duration of 15-30 minutes. The VR exposure will be passive, and the patient can control her observation inside the environment by herself, simply by moving her head. During this period, at any time and for any reason, the patient can discontinue the use of the VR session simply by self-removing the helmet
| Study group | Role | What they receive |
|---|---|---|
| Control group | No intervention | Patients who will be randomized to the control group will be waiting for the ET procedure without any intervention and without any deviation from the standard of care |
| Study group | Experimental | Exposure to virtual reality environment exposure Receives: Device: Virtual reality |
What is being measured
The primary outcome is the main question the study is designed to answer.
Clinical pregnancy rate (CPR)
The difference in CPR (determined by sonographic evidence of a gestational sac and fetal heart rate at 6 weeks' gestation by transvaginal ultrasound) between the study and the control group. An increase of 15% in the clinical pregnancy rate in the study group will be considered as significant.
Measured: Assessed 4 weeks after ET (= 6 weeks of gestation)
Secondary outcomes (3)
Stress levels - STAI questionnaires
Will be assessed using the STAI questionnaire (scored 20-80 points). We are expecting a 25% decrease in the STAI scores in the study group to be significant, based on clinical experience with similar patient population
Measured: Questionnaires will be filled out in 3 different time points during the study: 1) Day 1 of recruitment, before beginning the medications for endometrial preparation 2) ET day, 30-60 minutes before ET 3) ET day, 5-10 minutes after ET procedure
Salivary alpha amylase (SAA) levels
Salivary samples will be collected and analyzed. A 30% decrease in the SAA levels in the study group vs control will be considered significant, based on a previous study
Measured: Samples will be collected in 3 different time points during the study: 1) Day 1 of recruitment, before beginning the medications for endometrial preparation 2) ET day, 30-60 minutes before ET 3) ET day, 5-10 minutes after ET procedure
Sympathetic autonomous nervous system expressions
Heart rate \& blood pressure measurements. These 2 sympathetic nervous system variables were selected as physical parameters which may indicate anxiety. A significant change between the groups will be based on clinical experience with similar patient populations. An estimated one-third (33%) of the patients would experience elevated blood pressure and/or heart rate readings in the moderate-to-severe range during the standard procedure. VR exposure therapy is expected to reduce this proportion to 20%.
Measured: Measurements will be taken in 3 different time points during the study: 1) Day 1 of recruitment, before beginning the medications for endometrial preparation 2) 30-60 minutes before ET 3) ET day, 5-10 minutes after ET procedure
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 May 2020
- Study start31 May 2019
- Primary completion1 Aug 2023
- Study completion1 Aug 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (33)Papers the sponsor has linked to this study.
- Other trials for IVF OutcomesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Care provider
- Enrolment
- 350 participants (actual)
Sponsor and investigators
- Lead sponsor
- Dr cliff Librach
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Dr cliff Librach, Create Fertility Center
- Investigators
- Clifford Librach, MD, Principal investigator, CReATe Fertility Centre
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04394962
- Sponsor's protocol ID
- CL1E
- Status last verified
- Mar 2024
- First submitted
- 6 May 2020
- Last updated
- 7 Mar 2024
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Sunderam S, Kissin DM, Crawford SB, Folger SG, Boulet SL, Warner L, Barfield WD. Assisted Reproductive Technology Surveillance - United States, 2015. MMWR Surveill Summ. 2018 Feb 16;67(3):1-28. doi: 10.15585/mmwr.ss6703a1.
PubMed 29447147Porat-Katz A, Eldar-Geva T, Kahane A, Laufer N, Younis JS, Radin O, Paltiel O. Use of complementary medical therapies by Israeli patients undergoing in vitro fertilization. Int J Gynaecol Obstet. 2015 May;129(2):133-7. doi: 10.1016/j.ijgo.2014.11.021. Epub 2015 Feb 7.
PubMed 25687239Verhaak CM, Smeenk JM, Evers AW, Kremer JA, Kraaimaat FW, Braat DD. Women's emotional adjustment to IVF: a systematic review of 25 years of research. Hum Reprod Update. 2007 Jan-Feb;13(1):27-36. doi: 10.1093/humupd/dml040. Epub 2006 Aug 29.
PubMed 16940360Yong P, Martin C, Thong J. A comparison of psychological functioning in women at different stages of in vitro fertilization treatment using the mean affect adjective check list. J Assist Reprod Genet. 2000 Nov;17(10):553-6. doi: 10.1023/a:1026429712794.
PubMed 11209535Kondoh E, Okamoto T, Higuchi T, Tatsumi K, Baba T, Murphy SK, Takakura K, Konishi I, Fujii S. Stress affects uterine receptivity through an ovarian-independent pathway. Hum Reprod. 2009 Apr;24(4):945-53. doi: 10.1093/humrep/den461. Epub 2008 Dec 20.
PubMed 19098291Levitas E, Parmet A, Lunenfeld E, Bentov Y, Burstein E, Friger M, Potashnik G. Impact of hypnosis during embryo transfer on the outcome of in vitro fertilization-embryo transfer: a case-control study. Fertil Steril. 2006 May;85(5):1404-8. doi: 10.1016/j.fertnstert.2005.10.035. Epub 2006 Mar 29.
PubMed 16566936Fanchin R, Righini C, de Ziegler D, Olivennes F, Ledee N, Frydman R. Effects of vaginal progesterone administration on uterine contractility at the time of embryo transfer. Fertil Steril. 2001 Jun;75(6):1136-40. doi: 10.1016/s0015-0282(01)01787-3.
PubMed 11384639Fanchin R, Righini C, Olivennes F, Taylor S, de Ziegler D, Frydman R. Uterine contractions at the time of embryo transfer alter pregnancy rates after in-vitro fertilization. Hum Reprod. 1998 Jul;13(7):1968-74. doi: 10.1093/humrep/13.7.1968.
PubMed 9740459Zhu L, Che HS, Xiao L, Li YP. Uterine peristalsis before embryo transfer affects the chance of clinical pregnancy in fresh and frozen-thawed embryo transfer cycles. Hum Reprod. 2014 Jun;29(6):1238-43. doi: 10.1093/humrep/deu058. Epub 2014 Mar 23.
PubMed 24664129Boivin J, Takefman JE. Stress level across stages of in vitro fertilization in subsequently pregnant and nonpregnant women. Fertil Steril. 1995 Oct;64(4):802-10. doi: 10.1016/s0015-0282(16)57858-3.
PubMed 7672154Csemiczky G, Landgren BM, Collins A. The influence of stress and state anxiety on the outcome of IVF-treatment: psychological and endocrinological assessment of Swedish women entering IVF-treatment. Acta Obstet Gynecol Scand. 2000 Feb;79(2):113-8. doi: 10.1034/j.1600-0412.2000.079002113.x.
PubMed 10696958Eugster A, Vingerhoets AJ, van Heck GL, Merkus JM. The effect of episodic anxiety on an in vitro fertilization and intracytoplasmic sperm injection treatment outcome: a pilot study. J Psychosom Obstet Gynaecol. 2004 Mar;25(1):57-65. doi: 10.1080/01674820410001737441.
PubMed 15376405Friedler S, Glasser S, Azani L, Freedman LS, Raziel A, Strassburger D, Ron-El R, Lerner-Geva L. The effect of medical clowning on pregnancy rates after in vitro fertilization and embryo transfer. Fertil Steril. 2011 May;95(6):2127-30. doi: 10.1016/j.fertnstert.2010.12.016. Epub 2011 Jan 6.
PubMed 21211796Manheimer E, van der Windt D, Cheng K, Stafford K, Liu J, Tierney J, Lao L, Berman BM, Langenberg P, Bouter LM. The effects of acupuncture on rates of clinical pregnancy among women undergoing in vitro fertilization: a systematic review and meta-analysis. Hum Reprod Update. 2013 Nov-Dec;19(6):696-713. doi: 10.1093/humupd/dmt026. Epub 2013 Jun 27.
PubMed 23814102Qian Y, Xia XR, Ochin H, Huang C, Gao C, Gao L, Cui YG, Liu JY, Meng Y. Therapeutic effect of acupuncture on the outcomes of in vitro fertilization: a systematic review and meta-analysis. Arch Gynecol Obstet. 2017 Mar;295(3):543-558. doi: 10.1007/s00404-016-4255-y. Epub 2016 Dec 19.
PubMed 27995371
Study at a glance
From the registry record, last updated by the sponsor on 7 Mar 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Use of Virtual Reality Technology in Infertile Women Undergoing in Vitro Fertilization-embryo Transfer: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT04394962
- Acronym / sponsor ID
- CL1E
- Conditions
- IVF Outcomes, Stress Levels
- Keywords
- Virtual reality, In vitro fertilization, Embryo transfer
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 350 participants (actual)
- Lead sponsor
- Dr cliff LibrachUniversity, hospital or other
- Study start
- 31 May 2019 (actual)
- Primary completion
- 1 Aug 2023 (actual)
- Study completion
- 1 Aug 2023 (actual)
- First posted
- 20 May 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The study will examine the effect of exposure to virtual reality on stress levels and pregnancy rates, in infertile women undergoing in vitro fertilization embryo transfer
Detailed description
In vitro fertilization (IVF) treatment involving ovarian stimulation, oocyte retrieval and embryo transfer (ET) is an effective treatment for various causes of infertility. Despite advances in ovarian stimulation regimens and laboratory conditions, many IVF cycles do not result in pregnancy, and repeated treatment cycles are required. According to the latest Assisted reproductive technology (ART) surveillance report in the United states, of 143,286 procedures that progressed to the ET stage, 50.9% resulted in a pregnancy and 41.4% in a live-birth. Achieving higher pregnancy and live birth rates remains a leading priority of IVF units worldwide. Both IVF practitioners and patients keep searching for new ways to improve reproductive outcomes.
IVF is a multidimensional stressor. The treatment itself constitutes the primary stressor and is most likely to evoke anxiety. The highest anxiety scores were experienced before embryo transfer and were comparable to anxiety scores obtained from surgical female patients in the immediate preoperative period. Hence, it is not surprising that ET is defined by many investigators as a crucial event for determining IVF outcome, and many patients perceive it as the culmination of the IVF treatment. The stress this procedure may cause can result in a variety of autonomous nervous system expressions, altered uterine gene expression, resulting in decreased uterine receptivity, or an increase in uterine contraction frequency, which may be inversely correlated to embryo implantation and pregnancy rates in IVF. Several studies found that women who did not become pregnant with IVF, reported experiencing more stress during treatment than those who achieved pregnancy.
Although the exact mechanism whereby stress interferes with reproductive processes is not fully understood, experimental evidence increasingly indicates that lower stress levels result in better fertility treatment outcome.
The use of complementary medicine or adjuvant therapies to reduce psychological stress during ART therapy and improve IVF outcomes is increasing. Various alternative therapies have been proposed to improve reproductive outcomes during IVF treatment, such as acupuncture and Chinese herbal medicines. However, the impact of these therapies on IVF outcomes was inconclusive.
The impact of medical clowning as a stress-reducing technique for 12-15 minutes after ET was found to increase the pregnancy rate - 36.4% in the intervention group compared with 20.2% in the control group. Other interventions, specifically prior or during the IVF-ET procedure itself have been studied in the context of improving cycle outcome and/or reducing anxiety levels.
In order to assess anxiety levels before and after interventions, most of these studies included the validated "State-Trait Anxiety Inventory" (STAI) questionnaire, which is a self-assessment questionnaire, consisting of 40 items rated on 4-point Likert scale. The scale consists of two sub-dimensions: the "state anxiety" has 20 items and is used to determine what is felt at a specific moment under certain conditions, and the "trait anxiety" has 20 items and is used to determine what has been felt in the last seven days. Higher scores are positively correlated with higher levels of anxiety. Other studies assessing stress related to ET procedure used salivary a-amylase (SAA). SAA measurement presents a non-invasive and a highly reliable indicator of sympathetic-adrenal medullary activity can be used as a physiologic indicator of the acute stress response.
The impact of hypnosis during ET on the outcome of IVF was studied in 89 patients, compared with controls. The results suggested that the use of hypnosis during ET may significantly improve the IVF-ET cycle outcome in terms of increased implantation rates (IR) and clinical pregnancy rates (CPR).
Harp therapy during ET of 90 IVF patients was found to significantly decrease levels of anxiety post transfer and having a positive effect on acute levels of stress, compared with controls. However, CPR was comparable between the harp group and the control group. Another study assessed the effectiveness of a deep relaxation massage therapy prior to frozen ET in 56 IVF patients. In patients using the massage therapy prior to ET, statistically significant increases in pregnancy and live birth rates were observed when compared with the control group (58.9% vs 41.7%, and 32.0% vs 20.3%, respectively). The researchers hypothesized these improvements were most likely due to a relaxing effect on patients and reduction in stress, leading to a reduction in uterine contractions.
A recent randomized controlled trial assessed the effect of music therapy in women undergoing IVF-ET. They examined the effect of music therapy before and after ET, on the anxiety levels and pregnancy rates in 89 IVF patients. The mean state anxiety scores decreased in both groups, however these changes did not reach statistical significance. CPR were comparable between the groups.
Virtual reality (VR) is a therapeutic approach which has been gaining attention over the past two decades for both medical and psychiatric purposes. VR is an advanced technological system that allows users to be transported into a 'virtual world'. Users are engaged in a fully immersive VR experience through a combination of technologies, including a head-mounted display, headphones with sound/music and noise reduction, and another device for manipulation/navigation of the virtual environment. Multimodal stimuli contribute to a sense of actual presence/immersion in the virtual world, thus making the VR experience distinct from a passive visual or auditory stimuli. Being a safe, non-invasive and easy to use technique, VR therapy has been explored for numerous health applications, showing positive outcomes in clinical conditions such as anxiety disorders, addictions, phobias, posttraumatic stress disorder, eating disorders, stroke rehabilitation, and pain management. A recent systematic review including 11 VR studies and 467 patients, concluded that VR's immersive, entertaining effects are useful for redirecting the patient's attention away from painful treatment experiences and reducing anxiety, discomfort, or unpleasantness. Other studies also showed a significant decrease in pain perception and state anxiety scores when treated with VR, as indicated by anxiety questionnaires, pulse rate reduction, and electroencephalogram (EEG) changes when treated with VR as compared with controls, all supporting the therapeutic potential of VR for anxiety management and stress reduction.
A study presented at the 2018 anesthesia congress in Europe (Unpublished data) compared the effect of two different VR sessions (distraction and hypnosis) before sedation, on the anxiety level and the following cycle outcomes in 100 IVF patients. The preliminary results of the study showed a reduction in the anxiety scores in both groups, however the differences between the groups did not reach statistical significance.
The aim of this study is to examine the effects of VR technology on the most stressful event during IVF-the transfer of embryos into the uterus. The investigators will use the STAI questionnaire to assess levels of anxiety experienced during the ET procedure, in participants exposed to VR session before the ET, compared with participants who are not exposed.
The investigators hypothesize that the use of this unique technology before the procedure may reduce stress levels and consequently improve implantation and pregnancy rates.
According to a recent literature review, there are no published studies examining the effect of VR prior to ET on IVF outcomes.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (care provider)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Control group | No intervention | –Patients who will be randomized to the control group will be waiting for the ET procedure without any intervention and without any deviation from the standard of care |
| Study group | Experimental | Device: Virtual realityExposure to virtual reality environment exposure |
Who may qualify
- Ages
- 21 to 54 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- 21-45-year-old female patients, if using own ovum. Patients above this age range may be approached for study if using a donated ovum, as long as "egg age" (age of donor at ovum pick up) falls in 21-45 age range.
- Undergoing frozen ET procedures, and approached for study on "Day 2 - Day 4" of ET transfer cycle.
- Ability to provide written consent to use VR technology before the ET procedure
Key exclusion criteria (3 listed)
- Contraindication to use VR technology (Epilepsy/previous seizure, claustrophobia, current migraine, heart disease, visual and/or auditory deficits/use of medical devices such as cardiac pacemaker or hearing aids)
- Anxiety disorder and/or Regular use of anti-anxiety medications
- Major uterine anomalies and/or uterine fibroids distorting the cavity
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Virtual realityAlso: "Oculus Rift" system, Immersive environmentPatients randomized to the study group, will be provided with the VR headset and sensors. The VR exposure will take place before the ET procedure, during their routine pre-transfer waiting period, in a private room. The patient will be able to choose between three different calming VR environments (3 scenes: beach sunset, palm tree patio or redwood forest) and will be exposed to the chosen VR environment for a continuous duration of 15-30 minutes. The VR exposure will be passive, and the patient can control her observation inside the environment by herself, simply by moving her head. During this period, at any time and for any reason, the patient can discontinue the use of the VR session simply by self-removing the helmet | Device | Study group |
Primary outcome
Clinical pregnancy rate (CPR)
Time frame: Assessed 4 weeks after ET (= 6 weeks of gestation)
The difference in CPR (determined by sonographic evidence of a gestational sac and fetal heart rate at 6 weeks' gestation by transvaginal ultrasound) between the study and the control group. An increase of 15% in the clinical pregnancy rate in the study group will be considered as significant.
3 secondary outcomes
Stress levels - STAI questionnaires
Time frame: Questionnaires will be filled out in 3 different time points during the study: 1) Day 1 of recruitment, before beginning the medications for endometrial preparation 2) ET day, 30-60 minutes before ET 3) ET day, 5-10 minutes after ET procedure
Salivary alpha amylase (SAA) levels
Time frame: Samples will be collected in 3 different time points during the study: 1) Day 1 of recruitment, before beginning the medications for endometrial preparation 2) ET day, 30-60 minutes before ET 3) ET day, 5-10 minutes after ET procedure
Sympathetic autonomous nervous system expressions
Time frame: Measurements will be taken in 3 different time points during the study: 1) Day 1 of recruitment, before beginning the medications for endometrial preparation 2) 30-60 minutes before ET 3) ET day, 5-10 minutes after ET procedure
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Mar 2024.
- Background: PubMed 29447147Sunderam S, Kissin DM, Crawford SB, Folger SG, Boulet SL, Warner L, Barfield WD. Assisted Reproductive Technology Surveillance - United States, 2015. MMWR Surveill Summ. 2018 Feb 16;67(3):1-28. doi: 10.15585/mmwr.ss6703a1.
- Background: PubMed 25687239Porat-Katz A, Eldar-Geva T, Kahane A, Laufer N, Younis JS, Radin O, Paltiel O. Use of complementary medical therapies by Israeli patients undergoing in vitro fertilization. Int J Gynaecol Obstet. 2015 May;129(2):133-7. doi: 10.1016/j.ijgo.2014.11.021. Epub 2015 Feb 7.
- Background: PubMed 16940360Verhaak CM, Smeenk JM, Evers AW, Kremer JA, Kraaimaat FW, Braat DD. Women's emotional adjustment to IVF: a systematic review of 25 years of research. Hum Reprod Update. 2007 Jan-Feb;13(1):27-36. doi: 10.1093/humupd/dml040. Epub 2006 Aug 29.
- Background: PubMed 11209535Yong P, Martin C, Thong J. A comparison of psychological functioning in women at different stages of in vitro fertilization treatment using the mean affect adjective check list. J Assist Reprod Genet. 2000 Nov;17(10):553-6. doi: 10.1023/a:1026429712794.
- Background: PubMed 19098291Kondoh E, Okamoto T, Higuchi T, Tatsumi K, Baba T, Murphy SK, Takakura K, Konishi I, Fujii S. Stress affects uterine receptivity through an ovarian-independent pathway. Hum Reprod. 2009 Apr;24(4):945-53. doi: 10.1093/humrep/den461. Epub 2008 Dec 20.
- Background: PubMed 16566936Levitas E, Parmet A, Lunenfeld E, Bentov Y, Burstein E, Friger M, Potashnik G. Impact of hypnosis during embryo transfer on the outcome of in vitro fertilization-embryo transfer: a case-control study. Fertil Steril. 2006 May;85(5):1404-8. doi: 10.1016/j.fertnstert.2005.10.035. Epub 2006 Mar 29.
- Background: PubMed 11384639Fanchin R, Righini C, de Ziegler D, Olivennes F, Ledee N, Frydman R. Effects of vaginal progesterone administration on uterine contractility at the time of embryo transfer. Fertil Steril. 2001 Jun;75(6):1136-40. doi: 10.1016/s0015-0282(01)01787-3.
- Background: PubMed 9740459Fanchin R, Righini C, Olivennes F, Taylor S, de Ziegler D, Frydman R. Uterine contractions at the time of embryo transfer alter pregnancy rates after in-vitro fertilization. Hum Reprod. 1998 Jul;13(7):1968-74. doi: 10.1093/humrep/13.7.1968.
- Background: PubMed 24664129Zhu L, Che HS, Xiao L, Li YP. Uterine peristalsis before embryo transfer affects the chance of clinical pregnancy in fresh and frozen-thawed embryo transfer cycles. Hum Reprod. 2014 Jun;29(6):1238-43. doi: 10.1093/humrep/deu058. Epub 2014 Mar 23.
- Background: PubMed 7672154Boivin J, Takefman JE. Stress level across stages of in vitro fertilization in subsequently pregnant and nonpregnant women. Fertil Steril. 1995 Oct;64(4):802-10. doi: 10.1016/s0015-0282(16)57858-3.
- Background: PubMed 10696958Csemiczky G, Landgren BM, Collins A. The influence of stress and state anxiety on the outcome of IVF-treatment: psychological and endocrinological assessment of Swedish women entering IVF-treatment. Acta Obstet Gynecol Scand. 2000 Feb;79(2):113-8. doi: 10.1034/j.1600-0412.2000.079002113.x.
- Background: PubMed 15376405Eugster A, Vingerhoets AJ, van Heck GL, Merkus JM. The effect of episodic anxiety on an in vitro fertilization and intracytoplasmic sperm injection treatment outcome: a pilot study. J Psychosom Obstet Gynaecol. 2004 Mar;25(1):57-65. doi: 10.1080/01674820410001737441.
Related trials for IVF Outcomes
RecruitingObservational study
Machine-Learning Prediction of Pregnancy Outcomes After Assisted Reproductive Treatments
IVF Outcomes, Prediction Models
Not yet recruitingObservational study
Effect of Body Mass Index on ICSI Outcomes
Infertility, Obesity
Active, not recruitingObservational study
Sperm Selection Strategies and Male-Factor Phenotypes in ICSI
Assisted Reproductive Technology, Assisted Reproductive Technology Outcomes
Recruiting
The Effect of Mindfulness-Based Lifestyle Support Program on Infertile Women
Fertility Disorders, Infertility (IVF Patients)
Recruiting
Effectiveness of Live Motile Sperm Sorting Device on IVF Outcomes in Advanced Paternal Age
Male Infertility, Advanced Paternal Age
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Clifford Librach, MD principal investigator
CReATe Fertility Centre
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Virtual reality in people with IVF Outcomes and Stress Levels, run by Dr cliff Librach at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 7 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Clinical pregnancy rate (CPR) (time frame: Assessed 4 weeks after ET (= 6 weeks of gestation)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04394962, which also lists 33 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Mar 2024.